ST Pharm Co.,Ltd. (KOSDAQ: 237690)

ST Pharm Co.,Ltd. Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	29,550	50,097	50,201	39,203	38,625	12,823
Short-Term Investments	80,759	40,000	-	44,000	84,001	38,170
Trading Asset Securities	-	-	-	10,013	18,011	14,046
Cash & Short-Term Investments	110,309	90,097	50,201	93,216	140,636	65,039
Cash Growth	151.12%	79.47%	-46.15%	-33.72%	116.24%	-39.62%
Accounts Receivable	44,645	120,566	94,210	62,949	45,435	35,425
Other Receivables	-	1,500	3,131	1,499	1,236	273.02
Receivables	44,645	122,066	97,341	64,448	46,671	35,698
Inventory	154,718	120,736	107,623	80,809	45,401	40,925
Prepaid Expenses	11,780	11,901	5,818	5,039	1,798	117.53
Other Current Assets	2,959	3,577	2,251	628.76	1,107	2,372
Total Current Assets	324,411	348,378	263,234	244,142	235,613	144,152
Property, Plant & Equipment	299,126	280,105	257,885	210,190	175,634	170,980
Long-Term Investments	15,544	10,728	11,492	13,264	7,756	3,006
Goodwill	-	9,950	8,947	8,455	8,044	7,791
Other Intangible Assets	13,363	3,513	3,532	4,164	1,952	1,310
Long-Term Deferred Tax Assets	6,930	7,498	17,127	15,732	14,699	12,674
Other Long-Term Assets	6,841	15,264	8,436	2,619	1,872	695.9
Total Assets	666,216	675,436	570,652	498,565	445,570	340,610
Accounts Payable	9,796	17,661	18,095	12,865	4,694	7,164
Accrued Expenses	-	8,264	9,365	6,558	3,097	2,216
Short-Term Debt	30,271	20,878	105,854	-	-	-
Current Portion of Long-Term Debt	8,333	8,333	8,293	15,000	-	19.5
Current Portion of Leases	1,391	1,039	1,185	587.24	894.1	423.65
Current Income Taxes Payable	492.78	4,430	2,377	1,322	-	-
Other Current Liabilities	26,030	23,139	34,054	16,243	9,925	6,404
Total Current Liabilities	76,313	83,745	179,224	52,575	18,610	16,227
Long-Term Debt	117,501	159,689	16,707	91,451	125,646	15,078
Long-Term Leases	2,048	2,143	2,481	479.1	386.54	472.78
Long-Term Unearned Revenue	-	-	-	956.3	1,698	1,808
Other Long-Term Liabilities	40,494	42,369	31,138	27,071	2,451	2,239
Total Liabilities	237,974	288,530	229,549	172,533	148,817	37,401
Common Stock	9,732	9,404	9,404	9,404	9,328	9,328
Additional Paid-In Capital	275,059	225,940	195,747	195,714	174,919	168,725
Retained Earnings	133,584	135,729	126,893	115,590	111,634	123,561
Comprehensive Income & Other	8,555	13,476	5,587	2,266	-552.72	-791.7
Total Common Equity	426,929	384,550	337,632	322,974	295,328	300,822
Minority Interest	1,314	2,356	3,471	3,058	1,425	2,387
Shareholders' Equity	428,243	386,906	341,103	326,033	296,753	303,209
Total Liabilities & Equity	666,216	675,436	570,652	498,565	445,570	340,610
Total Debt	159,543	192,082	134,521	107,517	126,927	15,994
Net Cash (Debt)	-49,234	-101,984	-84,320	-14,301	13,709	49,045
Net Cash Growth	-	-	-	-	-72.05%	-54.42%
Net Cash Per Share	-2611.24	-5422.17	-4483.00	-766.21	734.85	2628.89
Filing Date Shares Outstanding	19.46	18.81	18.81	18.81	18.66	18.66
Total Common Shares Outstanding	19.46	18.81	18.81	18.81	18.66	18.66
Working Capital	248,099	264,634	84,010	191,567	217,003	127,925
Book Value Per Share	21934.82	20445.26	17950.76	17171.46	15830.19	16124.69
Tangible Book Value	413,565	371,088	325,153	310,355	285,333	291,721
Tangible Book Value Per Share	21248.24	19729.50	17287.30	16500.56	15294.42	15636.85
Land	-	60,024	59,999	52,910	52,908	52,895
Buildings	-	146,984	118,168	102,362	103,273	101,985
Machinery	-	195,642	157,855	120,141	115,304	108,829
Construction In Progress	-	20,794	44,421	50,144	12,071	2,731

Source: S&P Capital IQ. Standard template. Financial Sources.